Co-Authors
This is a "connection" page, showing publications co-authored by Annalisa Patrizi and Ambra Di Altobrando.
Connection Strength
0.502
-
Rituximab: a safe therapeutic option during the COVID-19 pandemic? J Dermatolog Treat. 2020 Jul 29; 1.
Score: 0.224
-
Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases? J Eur Acad Dermatol Venereol. 2020 Jul; 34(7):e295-e297.
Score: 0.223
-
How infodemic during the COVID-19 outbreak influenced common clinical practice in an Outpatient Service of Severe Psoriasis. Dermatol Ther. 2020 11; 33(6):e14065.
Score: 0.056